Drugs / MSP01-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07181148 | Oct 2025 → Mar 2026 overdue | — | Mather's Pharm. Co., Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSP01-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07181148 ↗ |
| Route | Oral | “oral intake” NCT07181148 ↗ |